The phenotype and activation status of regulatory T cells during Friend retrovirus infection
- PMID: 24452537
- PMCID: PMC8206416
- DOI: 10.1007/s12250-014-3396-z
The phenotype and activation status of regulatory T cells during Friend retrovirus infection
Abstract
The suppressive capacity of regulatory T cells (Tregs) has been extensively studied and is well established for many diseases. The expansion, accumulation, and activation of Tregs in viral infections are of major interest in order to find ways to alter Treg functions for therapeutic benefit. Tregs are able to dampen effector T cell responses to viral infections and thereby contribute to the establishment of a chronic infection. In the Friend retrovirus (FV) mouse model, Tregs are known to expand in all infected organs. To better understand the characteristics of these Treg populations, their phenotype was analyzed in detail. During acute FV-infection, Tregs became activated in the spleen and bone marrow, as indicated by various T cell activation markers, such as CD43 and CD103. Interestingly, Tregs in the bone marrow, which contains the highest viral loads during acute infection, displayed greater levels of activation than Tregs from the spleen. Treg expansion was driven by proliferation but no FV-specific Tregs could be detected. Activated Tregs in FV-infection did not produce Granzyme B (GzmB) or tumor necrosis factor α (TNFα), which are thought to be a potential mechanism for their suppressive activity. Furthermore, Tregs expressed inhibitory markers, such as TIM3, PD-1 and PD-L1. Blocking TIM3 and PD-L1 with antibodies during chronic FV-infection increased the numbers of activated Tregs. These data may have important implications for the understanding of Treg functions during chronic viral infections.
Similar articles
-
Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells.mBio. 2019 Jan 22;10(1):e02578-18. doi: 10.1128/mBio.02578-18. mBio. 2019. PMID: 30670616 Free PMC article.
-
B Cell Requirement for Robust Regulatory T Cell Responses to Friend Retrovirus Infection.mBio. 2017 Aug 1;8(4):e01122-17. doi: 10.1128/mBio.01122-17. mBio. 2017. PMID: 28765225 Free PMC article.
-
Regulatory T cells suppress virus-specific antibody responses to Friend retrovirus infection.PLoS One. 2018 Apr 3;13(4):e0195402. doi: 10.1371/journal.pone.0195402. eCollection 2018. PLoS One. 2018. PMID: 29614127 Free PMC article.
-
Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection.Retrovirology. 2016 Apr 14;13:24. doi: 10.1186/s12977-016-0258-9. Retrovirology. 2016. PMID: 27076190 Free PMC article. Review.
-
Immune control and prevention of chronic Friend retrovirus infection.Front Biosci. 2007 Jan 1;12:1544-51. doi: 10.2741/2167. Front Biosci. 2007. PMID: 17127401 Review.
Cited by
-
Crosstalk of Microorganisms and Immune Responses in Autoimmune Neuroinflammation: A Focus on Regulatory T Cells.Front Immunol. 2021 Oct 7;12:747143. doi: 10.3389/fimmu.2021.747143. eCollection 2021. Front Immunol. 2021. PMID: 34691057 Free PMC article. Review.
-
PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia.PLoS Pathog. 2015 Dec 3;11(12):e1005270. doi: 10.1371/journal.ppat.1005270. eCollection 2015 Dec. PLoS Pathog. 2015. PMID: 26633181 Free PMC article.
-
Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study.Exp Ther Med. 2017 Apr;13(4):1490-1494. doi: 10.3892/etm.2017.4144. Epub 2017 Feb 21. Exp Ther Med. 2017. PMID: 28413498 Free PMC article.
-
Interaction of viruses with host immune system and immunomodulation in chronic viral infections.Virol Sin. 2014 Feb;29(1):1-2. doi: 10.1007/s12250-014-3437-7. Virol Sin. 2014. PMID: 24470264 Free PMC article. No abstract available.
-
Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signaling.J Immunol. 2014 Sep 15;193(6):2952-60. doi: 10.4049/jimmunol.1400649. Epub 2014 Aug 6. J Immunol. 2014. PMID: 25098294 Free PMC article.
References
-
- Akhmetzyanova I, Zelinskyy G, Schimmer S, Brandau S, Altenhoff P, Sparwasser T, Dittmer U. Tumor-specific cd4+ t cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory t cells. Cancer Immunol Immun: CII. 2013;62:257–271. doi: 10.1007/s00262-012-1329-y. - DOI - PMC - PubMed
-
- Antunes I, Tolaini M, Kissenpfennig A, Iwashiro M, Kuribayashi K, Malissen B, Hasenkrug K, Kassiotis G. Retrovirus-specificity of regulatory t cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology. Immunity. 2008;29:782–794. doi: 10.1016/j.immuni.2008.09.016. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials